Strong Revenue Growth:
ARR is described as more than tripling in 2025, with recurring subscription and services revenue up over 220% year over year. Announcements in early 2026 attribute this surge to expanding adoption among private‑equity sponsors and portfolio companies.
Product Line Growth:
The company has introduced and expanded offerings such as an AI‑powered Pricing Suite and healthcare‑focused Astradis capabilities, alongside fresh product and solution pages in 2026. This cadence signals continued investment in its decision‑intelligence platform.
Market Expansion:
The footprint has widened with new or expanded offices in Bengaluru, Dallas, New York, and Toronto, plus a larger Chicago space, while sponsor relationships reportedly doubled to extend reach across hundreds of billions in AUM. Public materials emphasize a growing base among PE sponsors and portfolio companies.
